Medtronic’s MiniMed joins Nasdaq
By HME News Staff
Updated 9:55 AM CDT, Tue March 17, 2026
GALWAY, Ireland, and NORTHRIDGE, Calif. – MiniMed Group, a subsidiary of Medtronic, has begun trading on the Nasdaq under the ticker symbol “MMED” in connection with its initial public offering (IPO). "Today marks an exciting milestone for both MiniMed and Medtronic,” said Geoff Martha, Medtronic chairman and CEO. “Despite a challenging market backdrop shaped by geopolitical uncertainty, the teams successfully executed an oversubscribed offering and the second largest IPO in medtech history. Establishing MiniMed as a standalone entity positions the company to operate with greater agility over the long term. At the same time, this transaction supports Medtronic's strategy to focus capital and resources on long term value creation opportunities that leverage our scale, synergies, and core competencies. We congratulate Que Dallara and our diabetes colleagues whose leadership and dedication made this moment possible." MiniMed previously announced the pricing of its IPO of 28 million shares at $20 per share. About a month before the IPO, Medtronic filed a Worker Adjustment and Retraining Notification (WARN) report to lay off 81 employees in Northbridge, Calif.
Comments